ROYAL BANK OF CANADA - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 8 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$272,000
-50.7%
15,518
-72.8%
0.00%
Q2 2021$552,000
-62.7%
56,982
-58.6%
0.00%
Q1 2021$1,480,000
-41.0%
137,801
-19.2%
0.00%
-100.0%
Q4 2020$2,508,000
+11842.9%
170,523
+11579.7%
0.00%
Q3 2020$21,000
+133.3%
1,460
+33.5%
0.00%
Q2 2020$9,000
-40.0%
1,094
-71.4%
0.00%
Q1 2020$15,000
+1400.0%
3,831
+427.0%
0.00%
Q4 2019$1,000727
-54.8%
0.00%
Q3 2019$01,607
+163.4%
0.00%
Q2 2019$0
-100.0%
610
-94.7%
0.00%
Q1 2019$8,000
+700.0%
11,462
+1779.0%
0.00%
Q4 2018$1,000
-75.0%
6100.0%0.00%
Q3 2018$4,0000.0%6100.0%0.00%
Q2 2018$4,000
-55.6%
610
-49.0%
0.00%
Q1 2018$9,000
+125.0%
1,197
+96.2%
0.00%
Q4 2017$4,000
-20.0%
610
-32.1%
0.00%
Q3 2017$5,000
+66.7%
898
+47.2%
0.00%
Q2 2017$3,000
-76.9%
610
-70.7%
0.00%
Q1 2017$13,000
+333.3%
2,084
+261.2%
0.00%
Q4 2016$3,000
-25.0%
577
+121.9%
0.00%
Q3 2016$4,000
+300.0%
260
+145.3%
0.00%
Q2 2016$1,0000.0%106
-25.9%
0.00%
Q1 2016$1,000
-66.7%
143
-36.4%
0.00%
Q4 2015$3,000
+200.0%
225
+476.9%
0.00%
Q3 2015$1,0000.0%390.0%0.00%
Q2 2015$1,0000.0%390.0%0.00%
Q1 2015$1,000390.0%0.00%
Q4 2014$0390.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders